Reimagining Treatments for Hearing Loss
More than 40 million people in the U.S. struggle with acquired sensorineural hearing loss, the most common type of hearing loss. This condition affects more than just hearing; it’s about communication and speech perception. Individuals may have difficulty speaking on the phone, struggle in school or at work and become socially isolated. What may start as a minor inconvenience can get progressively worse and is associated with other serious medical conditions like depression and dementia.
Current treatments can help make sounds louder, but we’re leading the creation of the first-ever disease-modifying therapy for sensorineural hearing loss — one that aims to restore hearing function and enhance the ability to clearly understand speech.
Leading a New Category in Regenerative Medicine
With regenerative medicine, we often think of a complex, risky and multi-step process. Removing cells from the body, re-engineering genetic structures, using viruses or other carriers to help the modified genes reach their target – all while trying to do so safely.
At Frequency, we have created a simpler way to unlock the potential of regenerative medicine. Our approach aims to restore human function with small molecule therapeutics by activating a person’s innate regenerative potential within the body.
News & Insights
November 22, 2021
Episode 3 Part 2 of the Overheard at Frequency podcast, with guest Carl LeBel, PhDListen Now
November 15, 2021
Frequency Therapeutics Provides Business Updates and Third Quarter 2021 Financial ResultsRead More
November 9, 2021